Taking a look on fungi in cystic fibrosis: More questions than answers

Agarwal, 2016, Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis, Expert Rev Respir Med, 10, 1317, 10.1080/17476348.2016.1249853 Armstead, 2014, Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis, PLOS ONE, 9, e98502, 10.1371/journal.pone.0098502 Bartemes, 2018, Innate and adaptive immune responses to fungi in the airway, J Allergy Clin Immunol, 142, 353, 10.1016/j.jaci.2018.06.015 Baxter, 2013, Novel immunologic classification of aspergillosis in adult cystic fibrosis, J Allergy Clin Immunol, 132, 560, 10.1016/j.jaci.2013.04.007 Baxter, 2013, IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis, Chest, 143, 1351, 10.1378/chest.12-1363 Beauvais, 2015, Aspergillus biofilm in vitro and in vivo, Microbiol Spectr, 3, 10.1128/microbiolspec.MB-0017-2015 Borman, 2010, Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi, Med Mycol, 48, S88, 10.3109/13693786.2010.511287 Botterel, 2018, Fungal and bacterial diversity of airway microbiota in adults with cystic fibrosis: concordance between conventional methods and ultra-deep sequencing, and their practical use in the clinical laboratory, Mycopathologia, 183, 171, 10.1007/s11046-017-0185-x Boyle, 2018, Laboratory diagnosis and characterization of fungal disease in patients with cystic fibrosis (CF): survey on current UK practice in a cohort of clinical microbiology laboratories, Mycopathologia, 183, 723, 10.1007/s11046-018-0251-z Busch, 1990, On the history of cystic fibrosis, Acta Univ Carol Med (Praha), 36, 13 Cant, 2014, CFTR structure and cystic fibrosis, Int J Biochem Cell Biol, 52, 15, 10.1016/j.biocel.2014.02.004 Casadevall, 2000, Host–pathogen interactions: the basic concepts of microbial commensalism, colonization, infection, and disease, Infect Immun, 68, 6511, 10.1128/IAI.68.12.6511-6518.2000 Casadevall, 2015, What is a host? Incorporating the microbiota into the damage-response framework, Infect Immun, 83, 2, 10.1128/IAI.02627-14 Chishimba, 2012, Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization, J Asthma, 49, 423, 10.3109/02770903.2012.662568 Chowdhary, 2014, Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview, Crit Rev Microbiol, 40, 30, 10.3109/1040841X.2012.754401 Cimon, 2001, Molecular epidemiology of airway colonisation by A. fumigatus in cystic fibrosis patients, J Med Microbiol, 50, 367, 10.1099/0022-1317-50-4-367 Coron, 2018, Toward the standardization of mycological examination of sputum samples in cystic fibrosis: results from a French multicenter prospective study, Mycopathologia, 183, 101, 10.1007/s11046-017-0173-1 Cystic Fibrosis Foundation, 2017 Deepak, 2019, Allergic bronchopulmonary mycosis due to fungi other than Aspergillus, Eur Ann Allergy Clin Immunol, 51, 75, 10.23822/EurAnnACI.1764-1489.87 Delhaes, 2019, Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: results from the international prospective study “MFIP”, J Cyst Fibros, 18, 212, 10.1016/j.jcf.2018.10.001 Elborn, 2016, Lancet, 388, 2519, 10.1016/S0140-6736(16)00576-6 Emiralioglu, 2016, Omalizumab treatment for allergic bronchopulmonary aspergillosis in cystic fibrosis, Ann Pharmacother, 50, 188, 10.1177/1060028015624204 Evans, 1998, Epidemiological concepts, 3 Fillaux, 2012, Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients, Scand J Infect Dis, 44, 842, 10.3109/00365548.2012.695454 Fillaux, 2014, Aspergillus sensitization or carriage in cystic fibrosis patients, Pediatr Infect Dis J, 33, 680, 10.1097/INF.0000000000000231 Fukutomi, 2015, Sensitization to fungal allergens: resolved and unresolved issues, Allergol Int, 64, 321, 10.1016/j.alit.2015.05.007 Glackin, 2009, Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis, Ir Med J, 102, 29 Granchelli, 2018, Microbial interactions in the cystic fibrosis airway, J Clin Microbiol, 56, 10.1128/JCM.00354-18 Greenberger, 2014, Allergic bronchopulmonary aspergillosis, J Allergy Clin Immunol Pract, 2, 703, 10.1016/j.jaip.2014.08.007 Grenouillet, 2018, Exophiala dermatitidis revealing cystic fibrosis in adult patients with chronic pulmonary disease, Mycopathologia, 183, 71, 10.1007/s11046-017-0218-5 Harun, 2019, Aspergillus and progression of lung disease in children with cystic fibrosis, Thorax, 74, 125, 10.1136/thoraxjnl-2018-211550 Hauser, 2011, Clinical significance of microbial infection and adaptation in cystic fibrosis, Clin Microbiol Rev, 24, 29, 10.1128/CMR.00036-10 Hedayati, 2019, Fungal epidemiology in cystic fibrosis patients with a special focus on Scedosporium species complex, Microb Pathog, 129, 168, 10.1016/j.micpath.2019.02.009 Homa, 2019, In vitro interactions of Pseudomonas aeruginosa with Scedosporium species frequently associated with cystic fibrosis, Front Microbiol, 10, 441, 10.3389/fmicb.2019.00441 Iturrieta-González, 2014, Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B, PLOS ONE, 9, e109553, 10.1371/journal.pone.0109553 Janahi, 2017, Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis, Ann Thorac Med, 12, 74, 10.4103/atm.ATM_231_16 Kaditis, 2017, Effect of allergic bronchopulmonary aspergillosis on FEV1 in children and adolescents with cystic fibrosis: a European Cystic Fibrosis Society patient registry analysis, Arch Dis Child, 102, 742, 10.1136/archdischild-2016-311132 Kaur, 2014, Biofilm formation by Aspergillus fumigatus, Med Mycol, 52, 2 Kerkmann, 1999, Red-pigmented Candida albicans in patients with cystic fibrosis, J Clin Microbiol, 37, 278, 10.1128/JCM.37.1.278-278.1999 Khan, 2019, Progression of cystic fibrosis lung disease from childhood to adulthood: neutrophils, neutrophil extracellular trap (NET) formation, and NET degradation, Genes (Basel), 10, e183, 10.3390/genes10030183 Kirchhoff, 2017, Biofilm formation of the black yeast-like fungus Exophiala dermatitidis and its susceptibility to antiinfective agents, Sci Rep, 7, 42886, 10.1038/srep42886 Kramer, 2015, Cohort study of airway mycobiome in adult cystic fibrosis patients: differences in community structure between fungi and bacteria reveal predominance of transient fungal elements, J Clin Microbiol, 53, 2900, 10.1128/JCM.01094-15 Krause, 2017, Mycobiome in the lower respiratory tract – a clinical perspective, Front Microbiol, 7, 2169, 10.3389/fmicb.2016.02169 Liu, 2013, What is the clinical significance of filamentous fungi positive sputum cultures in patients with cystic fibrosis?, J Cyst Fibros, 12, 187, 10.1016/j.jcf.2013.02.003 Mastella, 2000, Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis, Eur Respir J, 16, 464, 10.1034/j.1399-3003.2000.016003464.x Maturu, 2015, Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis, Clin Exp Allergy, 45, 1765, 10.1111/cea.12595 Mello, 2016, Assessment of biofilm formation by Scedosporium apiospermum, S. aurantiacum, S. minutisporum and Lomentospora prolificans, Biofouling, 32, 737, 10.1080/08927014.2016.1192610 Mirtajani, 2017, Geographical distribution of cystic fibrosis: the past 70 years of data analysis, Biomed Biotechnol Res J, 1, 105, 10.4103/bbrj.bbrj_81_17 Mouhajir, 2016, Long-term Rasamsonia argillacea complex species colonization revealed by PCR amplification of repetitive DNA sequences in cystic fibrosis patients, J Clin Microbiol, 54, 2804, 10.1128/JCM.01462-16 Muthig, 2010, Persistence of Candida species in the respiratory tract of cystic fibrosis patients, Med Mycol, 48, 56, 10.3109/13693780802716532 Nasri, 2019, Airway colonisation by Candida and Aspergillus species in Iranian cystic fibrosis patients, Mycoses, 62, 434, 10.1111/myc.12898 Nobile, 2015, Candida albicans biofilms and human disease, Annu Rev Microbiol, 69, 71, 10.1146/annurev-micro-091014-104330 Nové-Josserand, 2017, Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients, Pediatr Pulmonol, 52, 190, 10.1002/ppul.23612 O’Brien, 2017, The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung, FEMS Microbiol Lett, 364 Ohn, 2017, Question 11: How should allergic bronchopulmonary aspergillosis [ABPA] be managed in cystic fibrosis?, Paediatr Respir Rev, 24, 35 Orpha.net. https://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=ES&data_id=49&Disease_Disease_Search_diseaseGroup=fibrosis-quistica&Disease_Disease_Search_diseaseType=Pat&Enfermedad(es)/grupo%20de%20enfermedades=Fibrosis-qu-stica&title=Fibrosis%20qu%EDstica&search=Disease_Search_Simple (last accessed 16.06.19). Osterholm, 2000, Epidemiologic principles, 156 Pihet, 2009, Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis – a review, Med Mycol, 47, 387, 10.1080/13693780802609604 Proesmans, 2010, Use of nebulized amphotericin B in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis, Int J Pediatr, 2010, 376287, 10.1155/2010/376287 Quince, 2017, Shotgun metagenomics, from sampling to analysis, Nat Biotechnol, 35, 833, 10.1038/nbt.3935 Rautemaa, 2017, High level of β-(1,3)-d-glucan antigenaemia in cystic fibrosis in the absence of invasive fungal disease, Diagn Microbiol Infect Dis, 88, 316, 10.1016/j.diagmicrobio.2017.05.010 Reece, 2018, Aspergillus fumigatus inhibits Pseudomonas aeruginosa in co-culture: implications of a mutually antagonistic relationship on virulence and inflammation in the CF airway, Front Microbiol, 9, 1205, 10.3389/fmicb.2018.01205 Reichhardt, 2016, Fungal biofilm composition and opportunities in drug discovery, Future Med Chem, 8, 1455, 10.4155/fmc-2016-0049 Rougeron, 2014, Different colonization patterns of Aspergillus terreus in patients with cystic fibrosis, Clin Microbiol Infect, 20, 327, 10.1111/1469-0691.12323 Russell, 2013, The destructive combination of Scedosporium apiospermum lung disease and exuberant inflammation in cystic fibrosis, Paediatr Respir Rev, 14, S5 Saunders, 2016, Chronic Aspergillus fumigatus colonization of the pediatric cystic fibrosis airway is common and may be associated with a more rapid decline in lung function, Med Mycol, 54, 537, 10.1093/mmy/myv119 Sehgal, 2019, Prevalence of sensitization to Aspergillus flavus in patients with allergic bronchopulmonary aspergillosis, Med Mycol, 57, 270, 10.1093/mmy/myy012 Singh, 2018, Fungal pathogens in CF airways: leave or treat?, Mycopathologia, 18, 119, 10.1007/s11046-017-0184-y Scheffold, 2018, Fungus-specific CD4 T cells as specific sensors for identification of pulmonary fungal infections, Mycopathologia, 183, 213, 10.1007/s11046-017-0229-2 Schwarz, 2018, Progress in definition, prevention and treatment of fungal infections in cystic fibrosis, Mycopathologia, 183, 21, 10.1007/s11046-017-0182-0 Tracy, 2018, The myriad challenges of respiratory fungal infection in cystic fibrosis, Pediatr Pulmonol, 53, S75, 10.1002/ppul.24126 Träger, 2018, Serum (1→3)-β-d-glucan and galactomannan levels in patients with cystic fibrosis: a retrospective cohort study, BMC Pulm Med, 18, 52, 10.1186/s12890-018-0614-8 Tsui, 2016, Pathogenesis of Candida albicans biofilm, Pathog Dis, 74, 10.1093/femspd/ftw018 Von Graevenitz, 1977, The role of opportunistic bacteria in human disease, Annu Rev Microbiol, 31, 447, 10.1146/annurev.mi.31.100177.002311 Walicka-Serzysko, 2015, The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis – preliminary report, Dev Period Med, 19, 66 Ward, 2017, Infant fungal communities: current knowledge and research opportunities, BMC Med, 15, 30, 10.1186/s12916-017-0802-z Warris, 2019, Aspergillus colonization and antifungal immunity in cystic fibrosis patients, Med Mycol, 57, S118, 10.1093/mmy/myy074 Willger, 2014, Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis, Microbiome, 2, 40, 10.1186/2049-2618-2-40